Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

Yan Jiang,Zhen-Lin Zhang,Zhong-lan Zhang,Han Min Zhu,Yi Yong Wu,Qun Cheng,Feng Li Wu,Xiaoping Xing,Jian-Li Liu,Wei Yu,Xunwu Meng

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

2014

Yan Jiang
Zhen-Lin Zhang
Zhong-lan Zhang
Han Min Zhu
Yi Yong Wu
Qun Cheng
Feng Li Wu
Xiaoping Xing
Jian-Li Liu
Wei Yu
Xunwu Meng

Objective To evaluate whether the efficacy and safety of menatetrenone for the treatment of osteoporosis is noninferior to alfacalcidol in Chinese postmenopausal women.

Keywords:

Bone density
Drug
Medicine
Menatetrenone
Physical therapy
Clinical trial
Osteoporosis
Alfacalcidol
double blinded
postmenopausal women

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations